Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
Long-term prognosis of MAFLD patients according to non-invasive methods
Long-term prognosis of MAFLD patients according to non-invasive methods
Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements (regression poster)
Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements
Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)
Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)
Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure
Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure
Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome
Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome
LIVERFASt Demonstrates the Feasibility of a Screening Program for MASLD
LIVERFASt Demonstrates the Feasibility of a Screening Program for MASLD